Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Synovial and periarticular proteins is a collective term referring to the diverse array of proteins and macromolecules found within the synovial cavity and the surrounding periarticular tissues of joints. This group includes structural components like type II collagen and aggrecan, lubricating proteins such as lubricin (proteoglycan 4), and various inflammatory mediators like cytokines and matrix metalloproteinases (MMPs). While not a single molecular target, these proteins represent the collective site of action for various intra-articular therapies. Drugs such as corticosteroids (e.g., triamcinolone) and viscosupplements (e.g., hyaluronic acid) are administered locally to the joint space to modulate the inflammatory environment or restore the mechanical properties of the synovial fluid. Consequently, this term is often used in a broad pharmacological context to describe the targets of local joint treatments in conditions like rheumatoid arthritis and osteoarthritis.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Synovial and periarticular proteins.